Laser treatment for lipoatrophy in children with diabetes type 1
Tóm tắt
Lipoatrophy (LA) is one of the complications of insulin treatment. It has become rare thanks to insulin analogues but it can still be observed in patients with diabetes type 1(T1DM). No effective treatment exists. Herein, we report for the first time two children with T1DM and LA successfully treated with laser treatment. A 6-year-old child with T1DM presented with LA 4 months post-diagnosis. He was on continuous subcutaneous insulin infusion (CSII). LA presented on body sites where insulin catheter was never inserted. He underwent different treatment options with no positive effect. Laser treatment was tried with impressive improvement. The second 9-year-old child presented with LA 5 years postdiagnosis. He changed the insulin type, the site of insulin injection, and tried topical use of sodium chromoglycate cream with partial improvement. Laser treatment was finally used with remarkable outcome. Insulin-induced LA is now a rare skin complication with no effective treatment up to now. Laser treatment seems to be an effective treatment option.
Tài liệu tham khảo
Kordonouri O, Biester T, Schnell K, Hartmann R, Tsioli C, Fath M, et al. Lipoatrophy in children with type 1 diabetes: an increasing incidence? J Diabetes Sci Technol. 2015;9(2):206–8.
Kordonouri O, Biester T, Weidemann J, Ott H, Remus K, Grothaus J, et al. Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine? Pediatr Diabetes. 2020;21(7):1285–91.
Sawatkar GU, Kanwar AJ, Dogra S, Bhadada SK, Dayal D. Spectrum of cutaneous manifestations of type 1 diabetes mellitus in 500 South Asian patients. Br J Dermatol. 2014;171(6):1402–6.
Binder E, Lange O, Edlinger M, Meraner D, Abt D, Moser C, et al. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. Exper Clin Endocrinol Diabetes. 2015;123(4):260–4.
Holstein A, Stege H, Kovacs P. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf. 2010;9(2):225–31.
Shimizu I, Furuya K, Osawa H, Fujii Y, Makino H. A case of insulin-induced localized lobular panniculitis with evidence for the phagocytosis of insulin by histiocytes. Endocr J. 2007;54(3):477–80.
Phua EJ, Lopez X, Ramus J, Goldfine AB. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use. Diabetes Care. 2013;36(12):e204–5.
Banihashemi M, Nahidi Y, Maleki M, Esmaily H, Moghimi HR. Efficacy of fractional CO2 laser in treatment of atrophic scar of cutaneous leishmaniasis. Lasers Med Sci. 2016;31(4):733–9.
Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014;23(1):49–60.
Lan T, Xiao Y, Tang L, Hamblin MR, Yin R. Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: a prospective study. Lasers Surg Med. 2018;50(8):844–50.
Campolmi P, Bonan P, Cannarozzo G, Bruscino N, Moretti S. Efficacy and safety evaluation of an innovative CO2 laser/radiofrequency device in dermatology. J Eur Acad Dermatol Venereol. 2013;27(12):1481–90.
Brightman L, Goldman MP, Taub AF. Sublative rejuvenation: experience with a new fractional radiofrequency system for skin rejuvenation and repair. J Drugs Dermatol. 2009;8(11 Suppl):s9-13.
Cannarozzo G, Sannino M, Tamburi F, Chiricozzi A, Saraceno R, Morini C, et al. Deep pulse fractional CO2 laser combined with a radiofrequency system: results of a case series. Photomed Laser Surg. 2014;32(7):409–12.
Tenna S, Cogliandro A, Piombino L, Filoni A, Persichetti P. Combined use of fractional CO2 laser and radiofrequency waves to treat acne scars: a pilot study on 15 patients. J Cosmetic Laser Therapy. 2012;14(4):166–71.
Sirithanabadeekul P, Tantrapornpong P, Rattakul B, Sutthipisal N, Thanasarnaksorn W. Comparison of fractional picosecond 1064-nm laser and fractional carbon dioxide laser for treating atrophic acne scars: a randomized split-face trial. Dermatol Surg. 2020;47:e58–65.